Royalty Pharma Announces R&D Funding Collaboration With Biogen
Go back to Royalty Pharma Announces R&D Funding Collaboration With Biogen| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 59.45 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.45 | 52 Week High | $3.48 | |||
| Open | $59.45 | 52 Week Low | $0.80 | |||
| Day High | $59.45 | P/E | N/A | |||
| Day Low | $59.45 | EPS | $-1.54 | |||
| Volume | 7,776 | |||||
